Affiliation: University of Chicago
- An analysis of whether higher health care spending in the United States versus Europe is 'worth it' in the case of cancerTomas Philipson
Irving B Harris Graduate School of Public Policy Studies, University of Chicago, Illinois, USA
Health Aff (Millwood) 31:667-75. 2012..Our study suggests that the higher-cost US system of cancer care delivery may be worth it, although further research is required to determine what specific tools or treatments are driving improved cancer survival in the United States...
- Infectious disease transmission and infection-dependent matchingT Philipson
Department of Economics, University of Chicago, IL 60637, USA
Math Biosci 148:161-80. 1998..Evidence in support of the economic type of infection-dependent matching is presented, by using data on the joint distribution of partners' HIV statuses in a random sample of couples from San Francisco in 1988-1989...
- The long-run growth in obesity as a function of technological changeTomas J Philipson
Irving B Harris Graduate School of Public Policy Studies, Department of Economics, University of Chicago, 1155 East 60th Street, Chicago, IL 60637, USA
Perspect Biol Med 46:S87-107. 2003..We discuss the positive and normative impacts of direct and indirect public interventions to reduce obesity...
- Government perspective: food labelingTomas Philipson
The University of Chicago, Chicago, IL 60637, USA
Am J Clin Nutr 82:262S-264S. 2005..The Commissioner of the Food and Drug Administration has recently appointed an Obesity Working Group to develop proposals on pertinent topics of obesity, including the role of food labeling as a dietary guide...
- Pharmacy cost sharing, antiplatelet therapy utilization, and health outcomes for patients with acute coronary syndromeTomas J Philipson
University of Chicago, IL 60637, USA
Am J Manag Care 16:290-7. 2010..To examine how cost sharing for prescription drugs affects compliance with antiplatelet therapy and subsequent health outcomes among patients with acute coronary syndrome (ACS)...
- Cost-effectiveness as a price controlAnupam B Jena
Department of Economics and School of Medicine, University of Chicago, Illinois, USA
Health Aff (Millwood) 26:696-703. 2007..Empirical evidence from a case study of HIV/AIDS provides an illustration of our conclusions...
- Striking a balance on new technology. Cost-effectiveness analysis can help sort out emerging health care technologies, but what are the consequences for continued medical innovation?Tomas J Philipson
University of Chicago, USA
AHIP Cover 47:29, 31, 33. 2006
- Cost-effectiveness analysis and innovationAnupam B Jena
The University of Chicago, Chicago, IL, USA
J Health Econ 27:1224-36. 2008..To the extent that such incentives are deemed either too low or too high compared to dynamically efficient levels, CE thresholds may be appropriately raised or lowered to improve dynamic efficiency...
- Industry funding of the FDA: effects of PDUFA on approval times and withdrawal ratesErnst R Berndt
Sloan School of Management, Massachusetts Institute of Technology, 50 Memorial Drive, E52 452, Cambridge, MA 02142, USA
Nat Rev Drug Discov 4:545-54. 2005....
- OLD AGE LONGEVITY AND THE MARKET FOR LONG TERM CARETomas Philipson; Fiscal Year: 2001..Preliminary analysis of a subpart of the data that is to be collected more fully suggest that long-tenn care output contracts with male aging as predicted. ..